BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Archives
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • September 2024
  • August 2024
  • July 2024
  • May 2024
  • April 2024
  • December 2023
  • October 2023
  • August 2023
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • February 2022
  • December 2021
  • November 2021
  • September 2021
  • August 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
BioTech Health X
  • BioTech News
  • BioTech CEO Interviews
  • Contact Us
Subscribe

Browsing Tag

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)

1 post

Biotech NewsThis Autoimmune Drug Stock Is Quietly Building a Billion-Dollar Franchise: Aurinia Pharmaceuticals (AUPH)

  • BioTech Health X
  • December 31, 2025
What began as a focused scientific effort to improve outcomes for patients with complex autoimmune kidney disease has…
0 Shares
0
0
0
0
0
0
0
Recent Posts
  • Wall Street Is Losing Patience With Viking Therapeutics (VKTX)
  • Novavax Inc (NVAX) Might Be the Comeback Story the Biotech Market Is Missing
  • Ventyx Biosciences (VTYX) Could Be the Next Billion-Dollar Biotech Buyout
  • Monte Rosa Therapeutics (GLUE) Is Targeting Diseases Other Drugs Can’t Touch
  • Coeptis Therapeutics (COEP) Is Not Profitable Yet — and That’s Exactly Why It’s Interesting
Recent Comments
  • Novavax Announces Robust First Quarter 2024 Results and Strategic Partnerships • BioTech Health X on Novavax and Sanofi Forge $1.2 Billion Alliance to Boost COVID and Flu Vaccine Efforts
  • Thomas Shentz on Cellarity Expands Leadership Team to Continue Evolution of Breakthrough Platform to Encode Biology and Purposefully Create New Drugs
  • Tomasz Michałowski on Exclusive: Cel-Sci CEO Geert Kersten Talks Multikine, FDA Approval, CVM Future
  • Presenters Announced for 2021 William Blair Biotech Conference • BioTech Health X on William Blair Biotech Focus Conference 2021 Panel Schedule
Featured Posts
    • January 7, 2026
    Wall Street Is Losing Patience With Viking Therapeutics (VKTX)
    • January 7, 2026
    Novavax Inc (NVAX) Might Be the Comeback Story the Biotech Market Is Missing
    • January 7, 2026
    Ventyx Biosciences (VTYX) Could Be the Next Billion-Dollar Biotech Buyout
    • January 7, 2026
    Monte Rosa Therapeutics (GLUE) Is Targeting Diseases Other Drugs Can’t Touch
    • January 6, 2026
    Coeptis Therapeutics (COEP) Is Not Profitable Yet — and That’s Exactly Why It’s Interesting
Recent Posts
  • Here’s Why Apogee Therapeutics (APGE) Is Suddenly on the Radar of Biotech Investors
    • January 6, 2026
  • Could UnitedHealth Group (UNH) Be the Safest Way to Invest in Healthcare Growth?
    • January 6, 2026
  • SELLAS Life Sciences Group (SLS) Just Took a Big Step Toward Changing How Cancer Is Treated
    • January 6, 2026
Categories
  • BioTech CEO Interviews (9)
  • Biotech Info (5)
  • Biotech News (691)
  • Uncategorized (1)
Author
Hello, I’m
BioTech Health X
Follow
BioTech Health X
Designed & Developed by BioTech Health X
  • About BioTech Health X
  • List of Modern Life Science Technologies
  • Biotechnology Company Directory – List of Major Biotech Companies
  • Contact Us
  • Privacy Policy

Subscribe to
Our Updates

Back to top